|
NPDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.539760E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.357600E-02 |
| Normal-vs-Stage2 |
3.438400E-01 |
| Normal-vs-Stage3 |
4.438200E-03 |
| Normal-vs-Stage4 |
1.742350E-01 |
| Stage1-vs-Stage2 |
8.966200E-01 |
| Stage1-vs-Stage3 |
4.535700E-02 |
| Stage1-vs-Stage4 |
1.848620E-01 |
| Stage2-vs-Stage3 |
1.134360E-01 |
| Stage2-vs-Stage4 |
3.444400E-01 |
| Stage3-vs-Stage4 |
9.680600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.543300E-03 |
| Normal-vs-AfricanAmerican |
5.249900E-02 |
| Normal-vs-Asian |
2.492200E-01 |
| Caucasian-vs-AfricanAmerican |
9.022800E-01 |
| Caucasian-vs-Asian |
3.541200E-01 |
| AfricanAmerican-vs-Asian |
2.878800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.132000E-02 |
| Normal-vs-Female |
3.51520000000383E-05 |
| Male-vs-Female |
1.538550E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.760300E-03 |
| Normal-vs-Extreme_Weight |
3.660500E-02 |
| Normal-vs-Obese |
5.289800E-02 |
| Normal-vs-Extreme_Obese |
8.720200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.369800E-01 |
| Normal_Weight-vs-Obese |
2.519800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.390400E-01 |
| Extreme_Weight-vs-Obese |
7.577200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.915400E-01 |
| Obese-vs-Extreme_Obese |
4.849400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.832300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.875700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.594300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.580000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.682600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.513800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.466200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.459200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.458200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.553200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.828070E-02 |
| Normal-VS-Type2 PRCC |
2.150600E-01 |
| Normal-VS-KIRP CIMP |
1.263590E-03 |
| Normal-VS-Unclassified PRCC |
7.627800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.154200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.680400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.981000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.42619999999816E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.726000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.043600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.366000E-01 |
| Normal-vs-N1 |
2.320600E-03 |
| Normal-vs-N2 |
1.502770E-01 |
| N0-vs-N1 |
7.384100E-03 |
| N0-vs-N2 |
1.728760E-01 |
| N1-vs-N2 |
3.467400E-01 |
|
|
